We found that most immune checkpoint genes, including PD1 and PD-L1, are highly expressed in the high-risk subgroup, and their overexpression inhibits the normal function of immune cells, thereby promoting tumor progression.[53] This suggests that immune suppression mediated by inhibitory immune checkpoints contributes to unfavorable outcomes in the high-risk subgroup. The gene discussed is PDCD1; the disease is neoplasm.